TABLE 2.
Author | Year | N | Control rate | Overall survival |
---|---|---|---|---|
Gillenwater et al 65 | 2001 | 26 |
88% (3‐year LC) 95% (3‐year RC) |
77.4% (3‐year OS) |
Lewis et al 66 | 2006 | 169 |
88% (5‐year LRFS) 77% (5‐year RRFS) |
57.3% (5‐year OS) |
Clark et al 67 | 2006 | 66 |
84% (5‐year LC) 69% (5‐year RC) |
49% (5‐year OS) |
Pape et al 62 | 2011 | 25 | 88% (in‐field control) | NA |
Hui et al 68 | 2011 | 165 |
81% (in‐field control) 76% (5‐year actuarial LRC) |
45% (5‐year actuarial OS) |
Ghadjar et al 69 | 2011 | 118 |
94% (5‐year LRFS) 76% (5‐year RRFS) |
56% (5‐year OS) |
Fields et al 70 | 2012 | 75 |
97% (LC) 88% (RC) |
NA |
Kang et al 71 | 2012 |
32 43 |
89% (2‐year LRFS; primary site RT) 84% (2‐year RRFS; regional RT) |
No improvement in OS |
Bishop et al 72 | 2016 | 106 |
96% (5‐year actuarial LC) 96% (5‐year actuarial RC) |
58% (5‐year OS) |
Abbreviations: LC, local control; LRC, loco‐regional control; LRFS, loco‐regional recurrence‐free survival; NA, not available; OS, overall survival; RC, regional control; RRFS, regional recurrence‐free survival.